RxDoctor Payments Data

Stephanie Taylor

Infectious Disease · New Orleans, LANPI 1205855277

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Roche Molecular Systems, Inc. at 51.6% of the total. Reporting peaked in 2019 at $13,896 and has fallen 81.8% since, to $2,535 in 2024. Among infectious disease clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,611in general payments, 2019–2025

Across 23 payments — averaging $1070.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$13K
  • Roche Diagnostics Corporation$4K
  • Gen-probe Sales & Service, Inc.$4K
  • La Jolla Pharmaceutical Company$3K
  • GSK$690
  • Gilead$121
  • plus $115 from 1 others
$1,582,916in research payments, 2019–2025

Across 69 payments — averaging $22,941 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BD$1.2M
  • Gen-probe, Inc.$331K
  • GSK$42K
  • Roche Molecular Systems, Inc.$7K

What the payments were for

  • Consulting fees$10,56543%
  • Speaking & faculty fees$9,90840%
  • Travel & lodging$2,42910%
  • Food & beverage$1,7097%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Molecular Systems, Inc.5$12,688
Roche Diagnostics Corporation8$4,348
Gen-probe Sales & Service, Inc.3$4,113
La Jolla Pharmaceutical Company4$2,535
GSK1$690
Gilead1$121
Medical Device Business Services, Inc.1$115

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,611 in reported general payments places this provider in the 95th percentile of 105 infectious disease providers in Louisiana.

See all infectious disease providers in Louisiana

Other infectious disease in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →